Does CANDESARTAN Cause Pulmonary fibrosis? 378 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 378 reports of Pulmonary fibrosis have been filed in association with CANDESARTAN. This represents 4.2% of all adverse event reports for CANDESARTAN.
378
Reports of Pulmonary fibrosis with CANDESARTAN
4.2%
of all CANDESARTAN reports
180
Deaths
311
Hospitalizations
How Dangerous Is Pulmonary fibrosis From CANDESARTAN?
Of the 378 reports, 180 (47.6%) resulted in death, 311 (82.3%) required hospitalization, and 272 (72.0%) were considered life-threatening.
Is Pulmonary fibrosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CANDESARTAN. However, 378 reports have been filed with the FAERS database.
What Other Side Effects Does CANDESARTAN Cause?
Off label use (1,911)
Fatigue (1,468)
Dyspnoea (1,456)
Pain (1,455)
Drug ineffective (1,428)
Headache (1,371)
Nausea (1,282)
Dizziness (1,237)
Vomiting (1,202)
Diarrhoea (1,145)
What Other Drugs Cause Pulmonary fibrosis?
METHOTREXATE (2,912)
ADALIMUMAB (2,277)
RITUXIMAB (2,192)
ETANERCEPT (1,926)
TOCILIZUMAB (1,886)
ABATACEPT (1,828)
HYDROXYCHLOROQUINE (1,740)
LEFLUNOMIDE (1,731)
PREDNISONE (1,692)
INFLIXIMAB (1,595)
Which CANDESARTAN Alternatives Have Lower Pulmonary fibrosis Risk?
CANDESARTAN vs CANDESARTAN CILEXETIL
CANDESARTAN vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE
CANDESARTAN vs CANGRELOR
CANDESARTAN vs CANIS LUPUS FAMILIARIS SKIN
CANDESARTAN vs CANNABIDIOL